about
Central role of the threonine residue within the p+1 loop of receptor tyrosine kinase in STAT3 constitutive phosphorylation in metastatic cancer cellsPotent mitogenicity of the RET/PTC3 oncogene correlates with its prevalence in tall-cell variant of papillary thyroid carcinomaThe neuronal scaffold protein Shank3 mediates signaling and biological function of the receptor tyrosine kinase Ret in epithelial cellsA PCR-mutagenesis strategy for rapid detection of mutations in codon 634 of the ret proto-oncogene related to MEN 2A.Neutralizing aptamers from whole-cell SELEX inhibit the RET receptor tyrosine kinaseFAK acts as a suppressor of RTK-MAP kinase signalling in Drosophila melanogaster epithelia and human cancer cellsDifferential activities of the RET tyrosine kinase receptor isoforms during mammalian embryogenesisGrap-2, a novel RET binding protein, is involved in RET mitogenic signaling.Genomic basis for coral resilience to climate change.Nucleic acid aptamers in cancer medicine.Sunitinib malate for the treatment of solid tumours: a review of current clinical data.Effects of siRNA on RET/PTC3 junction oncogene in papillary thyroid carcinoma: from molecular and cellular studies to preclinical investigationsCell-specific aptamers for targeted therapies.Clinical targeting of mutated and wild-type protein tyrosine kinases in cancer.The role of the PAX8/PPARgamma fusion oncogene in the pathogenesis of follicular thyroid cancerFormation of pseudosymmetrical G-quadruplex and i-motif structures in the proximal promoter region of the RET oncogene.Phosphotyrosine 1062 is critical for the in vivo activity of the Ret9 receptor tyrosine kinase isoform.MEK inhibitor PD0325901 significantly reduces the growth of papillary thyroid carcinoma cells in vitro and in vivoCo-registration of glucose metabolism with positron emission tomography and vascularity with fluorescent diffuse optical tomography in mouse tumorsLoss of CCDC6, the first identified RET partner gene, affects pH2AX S139 levels and accelerates mitotic entry upon DNA damage.Identification of sumoylation sites in CCDC6, the first identified RET partner gene in papillary thyroid carcinoma, uncovers a mode of regulating CCDC6 function on CREB1 transcriptional activity.High rate of BRAF and RET/PTC dual mutations associated with recurrent papillary thyroid carcinomaInvolvement of H4(D10S170) protein in ATM-dependent response to DNA damage.Functions and mechanisms of receptor tyrosine kinase Torso signaling: lessons from Drosophila embryonic terminal development.A human yeast artificial chromosome containing the multiple endocrine neoplasia type 2B Ret mutation does not induce medullary thyroid carcinoma but does support the growth of kidneys and partially rescues enteric nervous system development in Ret-dThe Ret(C620R) mutation affects renal and enteric development in a mouse model of Hirschsprung's disease.Activated RET and ROS: two new driver mutations in lung adenocarcinoma.Causes of oncogenic chromosomal translocation.Inhibition of the growth of papillary thyroid carcinoma cells by CI-1040.Selective repression of RET proto-oncogene in medullary thyroid carcinoma by a natural alkaloid berberine.Differentiated thyroid cancer: management of patients with radioiodine nonresponsive disease.Nuclear structure in cancer cells.miRNA profiling, detection of BRAF V600E mutation and RET-PTC1 translocation in patients from Novosibirsk oblast (Russia) with different types of thyroid tumorsReceptor tyrosine kinase mutations in developmental syndromes and cancer: two sides of the same coinThe RET proto-oncogene: a molecular therapeutic target in thyroid cancer.RET receptor signaling: dysfunction in thyroid cancer and Hirschsprung's disease.A Case of medullary thyroid carcinoma with de novo V804M RET germline mutationAbsence of a specific radiation signature in post-Chernobyl thyroid cancersPapillary thyroid carcinoma: 6 cases from 2 families with associated lymphocytic thyroiditis harbouring RET/PTC rearrangements.RET rearrangements in post-Chernobyl papillary thyroid carcinomas with a short latency analysed by interphase FISH.
P2860
Q24563513-6EB31927-A55E-4B53-9B4E-0CD57C1D5A36Q24669934-544A38C0-35F5-47B9-AF9D-92454D2F8C96Q24676241-4E298FEB-D814-4F35-9607-D5F950FBD544Q24794563-B532EE3A-6B59-4651-9E4F-F8316DE92B72Q24803451-D2D4D8C0-86AD-4E49-A23D-504E0967F9F6Q27316587-AD44297F-403B-421D-836B-EEABA9156444Q28354358-48E82521-E7D2-4E45-BEBB-D27C832CFAC4Q30164567-F624E3EE-32B0-4405-9994-5AD2C79321A7Q30585033-DEB8DE95-27E6-43A6-9E00-0F6B2594142DQ30854890-A2C16BA4-6B00-46C7-B1F6-E75A64487125Q31037756-C122741E-1F7F-4111-ACC1-3A5764AEF148Q31159590-F9302C9A-F43D-46BD-93CF-F1BF893E539CQ33432043-C8A60BEB-035E-4190-978C-A76DAA135A11Q33602552-7D5083CC-D256-47C7-94C8-B107DD204941Q33770842-EE55C2ED-A7B5-43F3-94BF-EE3021026896Q34005475-12CCD389-CCA2-4197-A784-499980263C62Q34097428-2362C7CE-1CFD-4E95-995D-AC4B4ED5B823Q34109756-4336DA0D-1E21-4FC8-8E0F-594F0E9F094BQ34260608-824486D4-9084-4EE3-B66C-103D84BDB16EQ34288868-6AF5EFD1-72D2-4622-86FE-53F05007F167Q34474368-DD5C4AC6-66D9-4F85-90BB-70D62A5F7471Q34572289-2A23342A-37CD-4BB7-8899-23911564EC5AQ34617571-B0386D51-9CA6-4C31-BC35-A092242BB694Q34974027-FC9653EB-281F-4F7F-B875-B9CB8CC55391Q35083569-BBAF0479-1516-41AF-9056-FE02685EBFD9Q35088154-01AA7CA4-77C5-4C6F-B16E-915E8D3F723FQ35206630-1E08B50D-2619-46F7-968B-917A87B53954Q35570942-56B68EC9-DC7E-435F-BC56-75EBD67068E6Q35570948-AC5769BC-9A0B-4831-A6AD-8A2A3CC839EBQ35755355-01E7584D-F76C-449B-B9C5-635014972AD8Q35864072-A9625717-97E1-44A3-A6C8-08BD8A90630BQ35877173-9DC22BDF-6DB2-4F66-84C5-BDF1A1613951Q35951601-6503C707-B948-4E4B-B2AE-60389979C503Q36065321-315AD185-4783-4D31-AD73-2197AF607146Q36072495-63A14D9B-5A64-4547-89A8-9E2855BF9879Q36458528-C9C7E7AF-FDEB-4712-B3BB-C206C780277CQ36536295-CB19F763-9F7A-461D-802B-CCE44D05743CQ36616761-5B513900-3F83-4942-A117-0C1391328D0CQ36623366-09D33C5C-9CDA-48CF-977D-A7839D132913Q36626465-29EA7A24-F9FA-4A11-A05E-0990DF3AF0C7
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
The RET proto-oncogene in human cancers.
@ast
The RET proto-oncogene in human cancers.
@en
The RET proto-oncogene in human cancers.
@nl
type
label
The RET proto-oncogene in human cancers.
@ast
The RET proto-oncogene in human cancers.
@en
The RET proto-oncogene in human cancers.
@nl
prefLabel
The RET proto-oncogene in human cancers.
@ast
The RET proto-oncogene in human cancers.
@en
The RET proto-oncogene in human cancers.
@nl
P356
P1433
P1476
The RET proto-oncogene in human cancers.
@en
P2093
P2888
P304
P356
10.1038/SJ.ONC.1203857
P407
P577
2000-11-01T00:00:00Z
P5875
P6179
1033777274